Although tumor-specific antigens are expressed by CLL cells (e.g., the ROR1 antigen) and are further effectively presented by MHC class I and class II molecules, cognate T cells fail to mount strong anti-tumor immune responses [123,124,125,126]. The gene discussed is HLA-C; the disease is neoplasm.